Tuesday, 04 Nov 2025

STAT+: Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty

Written by
STAT News
Published
CEO Jacob Thaysen sees Illumina on track to meet his original goal of high single-digit revenue growth by 2027 despite unexpected headwinds.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago